Epidemiat maailmalla

Takaisin Kanadaan; Mitään oireyhtymää ei ole. Kaikki on kuvittelua. Hajaantukaa!


Canadian province has no mystery brain disease, panel finds​

Published
24 February


Health Minister Dorothy Shephard
Image source, Government of New Brunswick/YouTube
Image caption,
Health Minister Dorothy Shephard announced the findings on Thursday
A long-awaited report by Canadian health officials into a possible new brain disease has found that no such disorder exists.
It comes almost one year after the New Brunswick government raised alarm about mysterious symptoms that seemed to have struck 48 people in the province.
The afflicted suffered everything from anxiety and depression to muscle atrophy and hallucinations.
But officials said the symptoms were not evidence of a novel illness.
Family members of those affected said they were let down by the findings and accused health officials of choosing "to abandon scientific rigour in exchange for political expediency," when undertaking the study.
But the committee that oversaw the report "unanimously agreed that these 48 people should never have been identified as having a neurological syndrome of unknown cause," said Jennifer Russell, New Brunswick's chief medical officer.

"This does not mean that these people are not ill, it means they are ill with a known neurological condition," she said.
The committee - made up primarily of neurologists from New Brunswick - found "potential alternative diagnoses" for 41 of the 48 patients, including Alzheimer's disease, Lewy body dementia, post-concussion syndrome and cancer.
Concerns about transparency plagued the investigation, with family members of patients criticising what they described as a lack of communication. Canadian media reported that the country's top experts had been excluded from the process, including Alier Marrero, a Moncton-based neurologist who first identified the potential new disorder in 2015.
Of the 48 patients identified, Dr Marrero identified all but two.
On Thursday, families of those afflicted called for a full scientific investigation. "Our lives and the lives of our loved ones will not be railroaded by a slipshod investigation that offers no answers to our pain and suffering," they said.
 
An estimated 14.91 million people worldwide died in 2020 and 2021 due to the COVID-19 pandemic, according to an analysis of global excess deaths released Thursday by the World Health Organization.

The estimate—with a 95 percent confidence interval of 13.3 million to 16.6 million—is significantly larger than the number of reported deaths directly caused by COVID-19 during that time, which was around 5.42 million by official counts. But, estimates of excess death try to capture the true toll of the pandemic—direct and indirect deaths. The estimate is done by comparing the number of deaths that occurred during a time period to those expected to occur in that period based on historical mortality data and modeling. Such modeling also accounts for historical differences, such as fewer traffic and influenza deaths during the pandemic due to movement and health restrictions.

Thus, excess death estimates aim to capture not only reported COVID-19 deaths, but also unreported COVID-19 deaths and deaths indirectly caused by COVID-19. Those can include people dying of preventable, non-COVID conditions because they delayed or avoided health care in fear of becoming infected, or because their health care system was overburdened with COVID-19 patients and unable to provide optimal care.

“These sobering data not only point to the impact of the pandemic but also to the need for all countries to invest in more resilient health systems that can sustain essential health services during crises, including stronger health information systems,” WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a statement.

The estimates can point to the countries that struggled to respond to the pandemic and the actual devastating toll.
 
The omicron coronavirus variant caused a spike in cases of a potentially severe breathing condition in babies and toddlers, according to a hospital study recently published in the journal Pediatrics.

The study is small, focusing only on COVID-19-associated cases at one large children's hospital in Massachusetts during the pandemic. But, it provides some of the initial data on the subject and backs up anecdotes from health care providers that the latest pandemic variant causes more cases of laryngotracheobronchitis—aka croup—in younger children than earlier variants.

Generally, croup is a common upper-respiratory tract condition in which significant inflammation and swelling develop in the larynx and trachea, imperiling breathing. Croup is usually triggered by some type of viral infection, but allergies and other irritants can also be culprits. It can occur at any age but mostly strikes the tiny upper airways of infants and young children, ages 3 months to 5 years.

Croup gets its name from the characteristic "croupy" cough it causes, which is sometimes described as a seal-like barking cough. Other hallmarks of the condition are a harsh, grating sound when a patient breathes in—inspiratory stridor—and respiratory distress.

Before the omicron wave, COVID-19 was associated with croup in some children, but it didn’t appear to be a common outcome of the pandemic infection. That changed during the omicron wave when health care providers reported they saw more COVID-19-associated croup cases in young patients.

While data remains sparse on why that might be the case, experts speculate that early variants and the ancestral SARS-CoV-2 tended to target the lower respiratory tract, leading to more severe disease in older age groups. Meanwhile, Omicron seems to have a predilection for the upper-respiratory tract, which may partly explain why it's both more transmissible and associated with relatively milder illnesses in older age groups.

But, in very young children—who have tiny airways and are still ineligible for COVID-19 vaccination—omicron appears to pose a new risk.
 
Massachusetts officials on Wednesday reported a rare case of monkeypox in a man who recently traveled to Canada, and health officials are looking into whether it is connected to small outbreaks in Europe.

Monkeypox is typically limited to Africa, and rare cases in the US and elsewhere are usually linked to travel there. A small number of confirmed or suspected cases have been reported this month in the United Kingdom, Portugal and Spain.

Health officials in the US said they are in contact with officials in the UK and Canada as part of the investigation. But “at this point in time, we don’t have any information that links the Massachusetts case to cases in the UK,” said Jennifer McQuiston of the US Centers for Disease Control and Prevention.

Though it’s the only US case the CDC is aware of, “I do think we are preparing for the possibility of more cases,” she said.
 
Public health officials are to announce more UK monkeypox cases on Monday, as efforts ramp up to contain the first multinational outbreak of the virus that has led to cases in at least 14 countries.

The unusual outbreak of the rare disease has sparked a wave of contact tracing and testing, with the closest contacts of confirmed cases – such as partners and people in the same household – offered a vaccine and told to isolate at home for up to 21 days.

Under UK Health Security Agency (UKHSA) guidance, the same high-risk contacts are advised to avoid immunosuppressed people, pregnant women and children under 12, as they are more vulnerable to serious infections. Reports have said that one of the UK cases is a child who is in intensive care in London with the disease. The NHS and UKHSA said they would not discuss individual cases.

While some monkeypox patients have been admitted to hospital, many confirmed cases that do not need specialist care are told to isolate at home until local health protection teams are confident they are no longer infectious. “The vast majority of identified cases are isolating at home and do not require hospital admission,” said Dr Claire Dewsnap, president of the British Association for Sexual Health and HIV.
 
Lyön yhden koronarokotteen vetoa, että apinarokko on venäläisten bioase!

Matkustaminen on tiukemmalla kuin ennen koronaa ja silti moinen tauti on levinnyt yhtäkkiä yltympäriinsä pitkin Pohjois-Amerikkaa ja Länsi-Eurooppaa... Suomeenkin - sellaisen miehen kyydissä, joka ei edes ollut käynyt Afrikassa. Edes (alkuperäinen) korona ei levinnyt yhtä nopeasti...

Lopullista totuutta ei tietysti koskaan sanota ääneen...
 
  • Tykkää
Reactions: ctg
Lyön yhden koronarokotteen vetoa, että apinarokko on venäläisten bioase!

Matkustaminen on tiukemmalla kuin ennen koronaa ja silti moinen tauti on levinnyt yhtäkkiä yltympäriinsä pitkin Pohjois-Amerikkaa ja Länsi-Eurooppaa... Suomeenkin - sellaisen miehen kyydissä, joka ei edes ollut käynyt Afrikassa. Edes (alkuperäinen) korona ei levinnyt yhtä nopeasti...

Lopullista totuutta ei tietysti koskaan sanota ääneen...
Aivan selkeästi kohdistettu tämä apinarokko ruotsalaisia miehiä vastaan.. Homoilemalla tarttuu..
 
Barcelonan pakoputkimarkkinoilta voi tarttua mukaan yhtä sun toista sateenkaaren väristä, vaikka kuinka kuinka Pridenä, eli ylpeänä, marssisi
 
Ensimmäinen varmistettu apinarokkotartunta maassamme. Sen kunniaksi:

 
When Moritz Kraemer first heard about the new monkeypox outbreak spreading through the UK, Europe, and the US, it was not through conventional scientific channels, or from the UK Health Security Agency (UKHSA), but via Twitter. As each suspected case was reported, and infectious disease experts shared their theories in real time, Kraemer—an epidemiologist at the University of Oxford who specializes in modeling the spread of infectious diseases—became increasingly concerned.

“We realized that this outbreak was unusual in its geographic expansion, with some clusters not linked to travel,” he says. In the past, when monkeypox cropped up in Europe or North America, cases could be readily traced back to countries where the virus circulates. Not this time. To keep up with how the virus was spreading, Kraemer together with John Brownstein and colleagues at Global.health, swiftly created the Monkeypox Tracker, which collates information on confirmed and suspected cases. It is this tool that neatly visualizes all that is unusual about the new outbreak.

Although monkeypox is endemic in West and Central Africa, it is not known for being especially transmissible. It was first found in monkeys in 1958, but rodents and other small mammals are thought to be the main animal host, and the virus is most commonly transmitted through close contact between these creatures and humans, causing people to come down with a fever, as well as a telltale bumpy rash.
But this still doesn’t answer the prevailing question of why now? Studies show that monkeypox has been on the rise for several years in Nigeria, the Democratic Republic of the Congo (DRC), and other African nations, but the precise tipping point that has led to a much wider outbreak today remains a mystery. Scientists hope that further genetic sequencing and contact tracing will shed more light on exactly when and how the outbreak began.

“The two trends of declining immunity and growing air travel don’t explain why this is happening now and not a few years ago, or a few years in the future,” says Walker. “Maybe a random series of mutations in the last few months set this all off. Or maybe our luck ran out, and it took until now for a monkeypox case to make its way to a major population center, get on an airplane, and kickstart an outbreak without hitting a dead end.”
And while monkeypox can be lethal—the Congo Basin strain kills up to 10 percent of those infected—genomic sequences seem to indicate that the new outbreak involves the West African strain, which has a lower estimated fatality rate of 1 percent. So far, no patients are known to have become severely ill, and there are two vaccines already available in Europe and North America that prevent disease even if used up to four days after a person has been exposed.

Plus responses have been swift. The UK is already deploying ring vaccination strategies—vaccinating close contacts of those infected with monkeypox—while the UKHSA has issued a statement saying that those people should also self-isolate for 21 days and work from home. Last Friday, Belgium became the first country to introduce a mandatory 21-day quarantine for all monkeypox patients.
21-päivän karanteeni tarttuneille.
 
Lyön yhden koronarokotteen vetoa, että apinarokko on venäläisten bioase!

Matkustaminen on tiukemmalla kuin ennen koronaa ja silti moinen tauti on levinnyt yhtäkkiä yltympäriinsä pitkin Pohjois-Amerikkaa ja Länsi-Eurooppaa... Suomeenkin - sellaisen miehen kyydissä, joka ei edes ollut käynyt Afrikassa. Edes (alkuperäinen) korona ei levinnyt yhtä nopeasti...

Lopullista totuutta ei tietysti koskaan sanota ääneen...

Huoli pois, Kiina kehitti jo useita kuukausia sitten PCR-testin apinarokkoa varten. Veikkaan, että se on sellainen persreiän kautta otettava - muuten ei saada tarvittavaa shock and awe-efektiä aikaan.



Voi toki olla, että kinuskit ovat keksineet erinomaisen bisnesidean - kehitetään PCR-testi ja päästetään PCR-testiä vastaava virus vapaaksi. Profit.

Tätä puoltaa ainakin se, että edellisen Wuhanin labran virustehtailussa mukana olleita länkkäreitä ei ole vieläkään rangaistu. Eräskin jatkaa koe-eläinten turhaa tappamista, entistä uskomattomilla tavoilla.

---

Puskaratio kertoo, että Epsteinin kaverilla, Bill Gatesilla on varastossa jo rokotteet valmiina.
 
  • Tykkää
Reactions: ctg
The World Health Organization will convene its emergency committee of expert advisors Thursday, June 23, to consider whether it should declare the growing, multinational monkeypox outbreak a public health emergency of international concern (PHEIC).

As of Tuesday, June 14, WHO has received reports of more than 1,600 confirmed monkeypox cases and almost 1,500 suspected cases from 39 countries. Those countries include eight in which monkeypox infections were previously known to spill over from animals, and 32 newly affected countries, most of which are in Europe, but also include Australia and countries in the Americas and Eastern Mediterranean.

There have been 72 monkeypox deaths reported this year from African countries that have long been affected by limited spillovers. So far, there are no confirmed deaths among cases in newly affected countries, but WHO is seeking verification of a reported monkeypox-related death in Brazil.

"The global outbreak of monkeypox is clearly unusual and concerning," WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a press briefing Tuesday. For that reason, Tedros decided to convene the emergency committee to determine if it constitutes a PHEIC.

A PHEIC is WHO's highest level of alarm. The United Nations agency defines a PHEIC as "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response." This definition implies a situation that is "serious, sudden, unusual or unexpected." Previous events that reached the level of PHEIC include the current COVID-19 pandemic, the Zika outbreak of 2016, and the 2014 to 2016 West Africa Ebola epidemic.

In the press briefing Tuesday, Tedros boiled down the definition of a PHEIC to three primary criteria: that the situation is unusual, is affecting multiple countries, and would benefit from collaboration and coordination.

"I think it's now clear that there is an unusual situation, meaning even the virus is behaving unusually from how it used to behave in the past," Tedros said. "But not only that, it's also affecting more and more countries, and we believe that it needs some coordinated response because of the geographic spread."
 
Mutku ne rokotehaitat 😆 .

Niitä on ollut .. tai ainakin internetissä on kirjoiteltu että olis ollut haittoja. Montakin esimerkkitapausta on ja kuuluisat lääkäritkin on puhuneet asiasta.

Tuo ei ole hauskaa! Veljentyttäreni sai rokotehaitan.

Hän oli antamassa rokotuksia ja hänen kätensä kipeytyi monotonisesta työstä.
 
Laitan nyt tähän ketjuun tämän, koska mielestäni koko Korona on yksi näytös isompaa hommaa.

Sen verran alkuun itsestä, että en ole mikään foliohattu pahimmasta päästä, mutta en myöskään mielestäni hyväuskoinen hölmö. Mietin asioita yleensä monesta kulmasta ja luotan omiin päätelmiin. Siksi nyt haluan jakaa oman näkemykseni täällä.

Ja asiasta. Vaikea miettiä mistä alkaisin. Ensinnäkin, minusta tuntuu että nyt olemme jonkin melkoisesti isomman homman äärellä. Ei pelkästään me täällä forumilla, tai me täällä Suomessa, vaan koko maailman väestö. Viimeisten vuosien aikana kiihtyvällä tahdilla tapahtuneet erikoiset asiat on ainakin itseni herättänyt ajattelemaan, ettei tässä enää pelata pienillä panoksilla. Mistä sitten on kyse? Isossa kuvassa näkisin että kommunistinen kiina ja isot korporaatiot on lyönyt tassua. Miksi? Koska firmat tekee tiliä, kiina hoitaa tuotannon. win-win. Käsikassarana antifa ympäri maailman. Tämän takia isot toimijat kuten mm. Facebook tukee antifaa ja BLM liikettä. Miten korona liiittyy tähän? USA:n vaalivuosi. Halutaan varmistaa että kiiinalaisten, korporaatioiden ja antifan ehdokas Biden vie vaalit. Lasketaan kiinassa virus liikkelle. Laitetaan sosiaaliseen mediaan videoita miten ovia hitsataan kiinni, ihmisiä kuolee kadulle ja viruksesta varoittavia lääkäreitä katoaa. Kaikki tämä kusetusta. Länsimaat paniikkiiin. Jenkit paniikkiin. Herää kysymys, mikä firma on kehittänyt koronatestin? Onko kukaan kyseenalaistanut ko. testiä? Voiko olla että valmiiksi kuoleville ihmisille lyödään posiitiiviinen tulos ja luodaan paniikkia? Halutaan maskit naamaan ja ihmiset eristäytämään. Miksi? Halutaanko hallita? En tiedä. Kertokaa.
2 vuotta menty ja ajatus senkun vahvistuu. Vieläkö naurattaa? Vai onko ne simmut edelleen ummessa?
 
Back
Top